Pancreatic stem cell discovery opens door to regenerative treatments for diabetes Scientists at the Diabetes Research Institute have confirmed the existence of stem cells in the pancreas that can develop […]
Turns out, Bayer HealthCare’s faltering even before Monsanto enters the fold Industry watchers were worried about neglect for Bayer’s healthcare division when the company chased down its megamerger with agrochemical […]
Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis As opioid scrutiny intensifies around the country, Mallinckrodt has received another subpoena seeking information about its sales of the […]
AI and facial diagnosis company FDNA sets up genomics coalition Boston biotech FDNA has teamed up with several research organizations to create a consortium that will try to apply artificial […]
1 year later, RFK Jr.’s plan for vaccine safety commission seems stalled RFK Jr. said there’s been “zero progress” on the controversial vaccine safety commission, according to The Guardian. Source: […]
As diabetes heats up, Lilly looks for Trulicity edge with positive SGLT2 combo data Eli Lilly has some formidable competition coming in the GLP-1 diabetes class, so it’s wasting no […]
Generation Bio raises 0M for ‘druglike’ gene therapy Gene therapy startup Generation Bio has lost no time raising the resources it needs to take its programs forward into the clinic, […]
DBV climbs as messy milk allergy data open door to phase 3 DBV Technologies has posted results from a midphase trial of its milk allergy candidate Viaskin Milk. The study […]
New FTC rules hurt M&A prospects for hard-hit generics players The generics sector has been looking to M&A as a way to combat the pricing pressure crushing top lines around […]
Allergan was blasted for its unusual Mohawk patent license, and now it’s a total flop After months of criticism that even spilled into a judge’s opinion in a separate case, […]